Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
[14C]-NV-5138
SUPERNUS PHARMACEUTICALS, INC.
Healthy Volunteers
2 trials -
[14C]-PC14586
PMV Pharmaceuticals
Healthy Male Volunteers
1 trial -
[14C]-Paxalisib Capsule
KAZIA THERAPEUTICS LTD
Healthy
1 trial -
[14C]-TAK-385 Oral Solution
Takeda
Healthy Volunteers
1 trial -
[14C]-TAK-954
Takeda
Healthy Volunteers
1 trial -
[14C]-TVB-2640
Sagimet Biosciences
Healthy Volunteers
1 trial -
[14C]-benzo[a]pyrene
NORTHWEST BIOTHERAPEUTICS INC
Environmental Exposure
3 trials -
[14C]-etrumadenant
Arcus Biosciences
Healthy Participants
1 trial -
[14C]-olinciguat
Cyclerion Therapeutics
Healthy Volunteers
1 trial -
[14C]-praliciguat
Cyclerion Therapeutics
Healthy Volunteers
1 trial -
[14C]-rencofilstat 225mg
Hepion Pharmaceuticals
NASH With Fibrosis
1 trial -
[14C]-tebapivat
Agios Netherlands B.V.
Healthy Participants
1 trial -
[14C]Clifutinib
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Healthy Adult Male
1 trial -
[14C]HSK7653
The First People's Hospital of Lianyungang
Type II Diabetes
1 trial -
[14C]IDV184001AN
Indivior Pty Ltd
Opioid Use Disorder
1 trial -
[14C]SSS17
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Healthy Subjects (HS)
1 trial -
[14C]TGRX-326
The First People's Hospital of Lianyungang
Non Small Cell Lung Cancer
1 trial -
[177Lu]Lu-XT117
The First People's Hospital of Lianyungang
Advanced Solid Tumor
1 trial -
[18F]-Ξ±vΞ²6-BP
United Therapeutics Europe Ltd
Lung Cancer
1 trial -
[18F]APN-1607
The First People's Hospital of Lianyungang
Alzheimer Disease
1 trial -
[18F]F-AraG
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cancer
1 trial -
[18F]FP-R01-MG-F2
PLIANT THERAPEUTICS, INC.
Idiopathic Pulmonary Fibrosis
1 trial -
[18F]fluoro-PEG-folate PET/CT scan
BRIGHT MINDS BIOSCIENCES INC.
Epithelial Ovarian Cancer
1 trial -
[203Pb]VMT01
Perspective Therapeutics
Melanoma (Skin)
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources